The Hong Kong Bio-Med Innotech Association successfully hosted the "Hong Kong Life Science Story 2024" press conference on March 14, 2024. The sole preclinical CRO business among the ones chosen for the "Hong Kong Life Science Story 2024" is ZSHK Laboratories Limited.
"Hong Kong Life Sciences Story 2024" describes the life science innovation and entrepreneurship stories of 30 Hong Kong scientists and entrepreneurs, depicts the current status of Hong Kong's life sciences industry, scientific research strength, policy support, social recognition, infrastructure facilities, etc. It also builds Hong Kong's reputation and the life sciences industry business card at home and abroad to let the world see the strength of Hong Kong's life sciences industry.

【ZSHK Laboratories Limited was selected into “Hong Kong Life Sciences Story 2024”】

ZSHK Laboratories Limited is a biopharmaceutical pre-clinical research and development service company mainly engaged in pre-clinical research and evaluation services for drugs and medical devices. As a one-stop evaluation and research service platform, it provides services including pharmacology, pharmacodynamics, pharmacokinetics, toxicology and other safety-related studies for pharmaceutical developers and researchers worldwide.
ZSHK has established independent laboratories in Pingshan District of Shenzhen, Guangdong Province, and Suzhou Industrial Park and Suzhou New District, Jiangsu Province. ZSHK also jointly operated the Drug Safety Testing Center in Hong Kong Science Park with Hong Kong Science and Technology Parks Corporation. Paying active efforts in supply chain deploying, ZSHK has established breeding and research bases of experimental dogs and non-human primates in Hunan and Guangxi.